Naegleria fowleri, the single-celled organism responsible for a brain infection that kills more than 97 percent of those it strikes, has been detected in hot springs across Yellowstone National Park. Federal researchers first confirmed its presence at three geothermal sites during a 2001 survey, and a recent multi-year study using molecular testing found the pathogen in roughly a third of water samples collected from thermally heated recreational waters in western U.S. national parks, including Yellowstone. With millions of visitors drawn to the park’s geothermal features each summer, the findings raise pointed questions about monitoring gaps and the absence of updated cell-count data tied to current visitor patterns.
Why N. fowleri in Yellowstone demands attention right now
Primary amebic meningoencephalitis, or PAM, is the infection caused when N. fowleri enters the body through the nose, typically during swimming or submersion in warm freshwater. Between 1962 and 2024, the CDC documented U.S. cases with a fatality rate exceeding 97 percent. The infection is rare in absolute numbers, but its near-total lethality sets it apart from virtually every other waterborne pathogen visitors might encounter in a national park.
The concern is not hypothetical. A peer-reviewed study published in ACS ES&T Water surveyed thermally impacted recreational waters across western national parks using quantitative PCR and Sanger sequencing. Of 185 samples tested, 34 percent came back positive for N. fowleri, with concentrations ranging from 4.9 to 115.7 cells per liter. Positive detections included samples from Yellowstone. Those numbers give concrete shape to a risk that park signage tends to describe only in general terms.
A working hypothesis among researchers is that warmer baseline water temperatures in northern-latitude geothermal features could be increasing the probability of detectable N. fowleri densities during peak visitor months. Testing that idea would require paired temperature and qPCR sampling repeated over multiple summers, but no publicly available dataset currently documents that kind of longitudinal monitoring at the specific Yellowstone sites where the amoeba has already been found.
Federal surveys that confirmed N. fowleri at Boiling River and beyond
The earliest confirmed detections trace to a 2001 investigation led by the U.S. Geological Survey. Researchers sampled 23 geothermal sites across Yellowstone and Grand Teton national parks. N. fowleri turned up at three Yellowstone locations: Boiling River, Seismic Geyser, and Mallard Lake Trail, according to the USGS water science center. A related paper, “Detection of Naegleria sp. in a thermal, acidic stream in Yellowstone National Park,” was published in the Journal of Eukaryotic Microbiology in 2003 and is cited by the National Park Service in its own explainer on the organism.
Separate USGS-published research also confirmed N. fowleri in Grand Teton National Park hot springs, using both culture-based and multiple molecular detection methods across water, sediment, and biofilm samples. That finding broadens the geographic footprint beyond Yellowstone’s borders and suggests the pathogen occupies a regional niche in northwestern Wyoming’s geothermal systems rather than appearing as an isolated anomaly at a single spring.
The more recent multi-park survey, which covered several western U.S. national parks, applied qPCR paired with Sanger sequencing to achieve higher detection sensitivity than the culture methods used in the early 2000s. Its 34 percent positivity rate across 185 samples and its measured concentration range of 4.9 to 115.7 cells per liter represent the most granular publicly available data on N. fowleri density in these recreational waters. Yet no primary USGS or National Park Service records provide post-2003 quantitative cell concentrations or seasonal sampling specifically from the three Yellowstone sites named in the original 2001 study.
Gaps in monitoring and what visitors still do not know
Several critical pieces of information remain absent from the public record. No lab-confirmed PAM infection has been directly attributed to exposure at Yellowstone hot springs in CDC case data. That absence is reassuring on its face, but a peer-reviewed CDC analysis published in Emerging Infectious Diseases has estimated that PAM cases may be underdiagnosed nationally, with deaths potentially misclassified due to imperfect surveillance. The rarity of the disease and the speed at which it kills make retrospective diagnosis difficult, so the zero-case count at Yellowstone may reflect incomplete reporting rather than confirmed safety.
Equally notable is the lack of recent, site-specific monitoring tied to visitor use patterns. Boiling River, one of the three sites where N. fowleri was detected in 2001, has historically been among Yellowstone’s most popular legal soaking areas because it mixes hot spring outflow with colder river water to create a bath-like temperature. Yet there is no publicly accessible, routinely updated dataset showing current N. fowleri levels there or at the other two confirmed sites. Without that information, visitors and local health officials are left to extrapolate from decades-old culture results and a newer, region-wide survey that does not break out Yellowstone’s individual features.
That data gap coincides with broader changes in visitation and climate. Yellowstone’s annual visitor numbers have climbed significantly over the past two decades, concentrating more people in and around thermal areas during the hottest months, when N. fowleri is most likely to thrive. At the same time, scientists are tracking warming trends in surface waters across the West, which could expand the seasonal and geographic window in which the amoeba reaches detectable densities. Yet there is still no requirement for national parks to publish real-time or even seasonal pathogen monitoring results for high-use geothermal swim sites.
Park messaging also lags behind the science in some respects. The National Park Service warns that N. fowleri can be present in warm freshwater and advises visitors to avoid getting water up their noses, but current brochures and online materials rarely reference the specific Yellowstone sites where the organism has been confirmed. Nor do they quantify the organism’s density in ways that might help visitors weigh relative risks, such as comparing cell counts at different temperatures or flow conditions. As a result, people who choose to wade or soak in legal areas may underestimate the hazard, while others may assume that all thermal features are equally dangerous, regardless of actual conditions.
What agencies could do next
Experts who study waterborne pathogens say the first step toward closing these gaps is straightforward: expand and standardize molecular monitoring at known and likely N. fowleri sites. That would mean regular qPCR sampling at Boiling River, Seismic Geyser, Mallard Lake Trail, and comparable locations in nearby parks, paired with temperature and flow measurements. Results could be posted seasonally on park websites or in visitor centers, much like current updates on bear activity or trail closures.
Another priority is clearer, more specific risk communication. Rather than generic cautions about “microorganisms,” signage at legal soaking areas could explain that a deadly amoeba has been detected in some Yellowstone waters, that infection occurs through the nose rather than by swallowing, and that simple steps-such as keeping one’s head above water, using nose clips, and avoiding submersion during very warm periods-can reduce but not eliminate risk. Online trip-planning pages could link directly to the Park Service overview on N. fowleri, which already summarizes what is known about the organism and its presence in park environments.
On the research side, sustained funding would be needed to build the kind of longitudinal dataset that is currently missing. The U.S. Geological Survey already distributes detailed hydrologic and geospatial products through outlets such as the USGS map store; adding standardized pathogen data layers for geothermal recreation sites could help scientists and public health officials identify trends, hotspots, and early warning signs. Collaborative projects with universities and state health departments could further refine sampling methods and explore how changing climate patterns intersect with N. fowleri ecology.
None of these measures would eliminate the risk of PAM in Yellowstone or any other park. The amoeba is a natural part of many warm freshwater systems, and the number of infections will likely remain very small even as detection improves. But the combination of a nearly always fatal outcome, documented presence in popular geothermal waters, and a lack of up-to-date, site-specific monitoring argues for more transparency and rigor. For now, visitors weighing whether to wade or soak in Yellowstone’s thermal areas must make decisions with incomplete information, trusting that an invisible hazard first confirmed more than two decades ago has not quietly grown alongside the crowds.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
